The National Institute for Health and Care Excellence (NICE) has issued a significant update to its guidance on preventing infective endocarditis, a serious heart infection. The new recommendations advise the use of antibiotic prophylaxis for individuals at high risk of developing the condition when undergoing procedures, including dental work, that could introduce bacteria into the bloodstream.
This marks a notable departure from NICE's 2008 guidelines, which largely discouraged the routine use of antibiotics for this purpose. The previous stance led to a substantial decrease in antibiotic prescriptions by healthcare professionals, including dentists, for patients undergoing procedures that might cause bacteraemia (bacteria in the blood).
Infective endocarditis is a life-threatening infection of the inner lining of the heart, often affecting heart valves. It carries a high mortality rate and can lead to severe complications such as heart failure, stroke, and organ damage. Individuals with pre-existing heart conditions, such as prosthetic heart valves, a history of infective endocarditis, or certain congenital heart defects, are considered to be at a higher risk.
The reversal in guidance comes after a period of debate and concerns raised by medical and dental professionals regarding a potential increase in infective endocarditis cases following the 2008 recommendations. Evidence and expert opinion have contributed to NICE's decision to revisit its position, aiming to strike a better balance between preventing a serious infection and the broader concerns about antibiotic resistance.
For dental practices and other healthcare providers, the updated guidance means a renewed focus on identifying high-risk patients. Dental professionals will now need to assess a patient's cardiac history more thoroughly to determine if antibiotic prophylaxis is necessary before procedures that could cause bleeding or introduce bacteria into the bloodstream, such as extractions or deep scaling.
The move is expected to lead to an increase in targeted antibiotic prescriptions for this specific patient group, with the aim of safeguarding vulnerable individuals from a potentially fatal infection. Healthcare organisations will be responsible for disseminating the updated guidance and ensuring that their staff are appropriately trained to implement the new recommendations effectively.